Contact this trialFirst, we need to learn more about you.
Alkylating agents
Chemotherapy + Targeted Therapy for Acute Lymphoblastic Leukemia
Recruiting2 awardsPhase 2
Seattle, Washington
This trial tests a new chemotherapy regimen with the addition of targeted therapy for the treatment of patients with newly diagnosed Philadelphia chromosome negative B acute lymphoblastic leukemia.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.